Atara Biotherapeutics, Inc. Annual Share-based Payment Arrangement, Expense in USD from 2012 to 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
Atara Biotherapeutics, Inc. quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from 2012 to 2023.
  • Atara Biotherapeutics, Inc. Share-based Payment Arrangement, Expense for the quarter ending June 30, 2024 was $6.34M, a 49.5% decline year-over-year.
  • Atara Biotherapeutics, Inc. Share-based Payment Arrangement, Expense for the twelve months ending June 30, 2024 was $35.8M, a 28% decline year-over-year.
  • Atara Biotherapeutics, Inc. annual Share-based Payment Arrangement, Expense for 2023 was $45.4M, a 15.7% decline from 2022.
  • Atara Biotherapeutics, Inc. annual Share-based Payment Arrangement, Expense for 2022 was $53.8M, a 0.05% decline from 2021.
  • Atara Biotherapeutics, Inc. annual Share-based Payment Arrangement, Expense for 2021 was $53.9M, a 4.9% increase from 2020.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Annual (USD)
Share-based Payment Arrangement, Expense, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $45.4M -$8.45M -15.7% Jan 1, 2023 Dec 31, 2023 10-K 2024-03-28
2022 $53.8M -$27K -0.05% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-28
2021 $53.9M +$2.51M +4.9% Jan 1, 2021 Dec 31, 2021 10-K 2023-02-08
2020 $51.4M -$345K -0.67% Jan 1, 2020 Dec 31, 2020 10-K 2023-02-08
2019 $51.7M +$17.9M +52.9% Jan 1, 2019 Dec 31, 2019 10-K 2022-02-28
2018 $33.8M +$10.7M +46.4% Jan 1, 2018 Dec 31, 2018 10-K 2021-03-01
2017 $23.1M +$6.32M +37.6% Jan 1, 2017 Dec 31, 2017 10-K 2020-02-27
2016 $16.8M +$6.53M +63.7% Jan 1, 2016 Dec 31, 2016 10-K 2019-02-26
2015 $10.3M +$150K +1.49% Jan 1, 2015 Dec 31, 2015 10-K 2018-02-27
2014 $10.1M +$8.39M +490% Jan 1, 2014 Dec 31, 2014 10-K 2017-03-09
2013 $1.71M +$1.42M +487% Jan 1, 2013 Dec 31, 2013 10-K 2016-03-04
2012 $292K Jan 1, 2012 Dec 31, 2012 10-K 2015-02-26
* An asterisk sign (*) next to the value indicates that the value is likely invalid.